Kymera Therapeutics
KYMR
#1949
Rank
C$14.11 B
Marketcap
C$165.37
Share price
-3.42%
Change (1 day)
77.58%
Change (1 year)

Earnings for Kymera Therapeutics (KYMR)

Earnings in 2026 (TTM): -C$0.49 Billion

According to Kymera Therapeutics's latest financial reports the company's current earnings are C$0.10 Billion. In 2025 the company made an earning of -C$0.45 Billion a decrease over its 2024 earnings that were of -C$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Kymera Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.49 Billion9.83%
2025 -C$0.45 Billion39.07%
2024 -C$0.33 Billion52.36%
2023 -C$0.22 Billion-5.09%
2022 -C$0.23 Billion54.56%
2021 -C$0.15 Billion119.98%
2020 -C$65.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.23 Billion-55.28%๐Ÿ‡บ๐Ÿ‡ธ USA